Table 2.
Home medications with corresponding doses, routes, and timing of last intake
| Medication | Dose/Formulation | Route | Last Intake | Notes/Relevance |
|---|---|---|---|---|
| Albuterol sulfate | 90 mcg per actuation (inhaler) | Inhalation | – | For COPD; no known bradycardic effect |
| Atorvastatin | 40 mg tablet | Oral | Morning of first bradycardia episode | Lipid-lowering agent; not associated with bradycardia |
| Breo Ellipta | 200/25 mcg (fluticasone furoate/vilanterol) inhaler | Inhalation | – | Long-acting β2-agonist and corticosteroid; unlikely contributor |
| Clopidogrel | 75 mg tablet | Oral | Morning of first bradycardia episode | Antiplatelet; no bradycardic effect |
| Famotidine | 40 mg tablet | Oral | Morning of first bradycardia episode | H2-blocker; no bradycardic effect |
| Lisinopril | 20 mg tablet | Oral | Before admission. Was held due to AKI | ACE inhibitor; may contribute indirectly via AKI, but not bradycardia |
| Oxycodone | 20 mg tablet | Oral | Morning of first bradycardia episode | Chronic use; opioid-induced bradycardia considered but unlikely primary cause |
None of the listed medications were deemed causal for the patient’s bradycardia.